In this study, we demonstrated that SCD1 in tumor cells suppresses antitumor CD8+ T cells through decreased numbers of DCs in tumors via the reduced level of DC-recruiting CCL4 caused by activation of the β-catenin pathway. The gene discussed is CCL4; the disease is neoplasm.